{"gene":"DTNBP1","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2001,"finding":"Dysbindin (DTNBP1) was identified as a novel coiled-coil-containing protein that binds directly to alpha- and beta-dystrobrevin in muscle and brain via yeast two-hybrid screen; dystrophin and alpha-dystrobrevin are co-immunoprecipitated with dysbindin, indicating dysbindin is a component of the dystrophin-associated protein complex (DPC). In brain, dysbindin localizes primarily to axon bundles and mossy fiber synaptic terminals in the cerebellum and hippocampus.","method":"Yeast two-hybrid screen, co-immunoprecipitation, co-localization by immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — original identification with yeast two-hybrid, reciprocal co-IP, and localization; strong foundational study","pmids":["11316798"],"is_preprint":false},{"year":2003,"finding":"Dysbindin is a component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1), which includes pallidin, muted, and cappuccino. Mutant sandy (sdy) mice lack dysbindin protein due to a deletion in Dtnbp1, and mutations in human DTNBP1 cause Hermansky-Pudlak syndrome type 7 (HPS-7), demonstrating dysbindin's role in vesicle trafficking to lysosome-related organelles such as melanosomes and platelet dense granules.","method":"Mouse genetic deletion model, protein complex identification, human mutation analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 — genetic null model + human disease mutation + complex identification; highly cited foundational paper","pmids":["12923531"],"is_preprint":false},{"year":2003,"finding":"Dysbindin binds to myospryn, a novel 413-kDa protein expressed in cardiac and skeletal muscle. Dysbindin and myospryn co-immunoprecipitate from muscle extracts and are extensively co-localized, identifying a tissue-specific ligand for dysbindin in muscle.","method":"Yeast two-hybrid screen, co-immunoprecipitation, co-localization by immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — yeast two-hybrid + reciprocal co-IP + co-localization, single lab","pmids":["14688250"],"is_preprint":false},{"year":2004,"finding":"Overexpression of dysbindin in primary cortical neurons increased expression of pre-synaptic proteins SNAP25 and synapsin I, and increased extracellular basal glutamate levels and evoked glutamate release. Conversely, siRNA-mediated knockdown reduced pre-synaptic protein expression and glutamate release, indicating dysbindin influences exocytotic glutamate release. Dysbindin overexpression also increased Akt phosphorylation and protected neurons against death via PI3-kinase-Akt signaling; siRNA knockdown diminished Akt phosphorylation and facilitated neuronal death.","method":"Neuronal overexpression, siRNA knockdown, glutamate release assay, Western blot for Akt phosphorylation, pharmacological inhibition (LY294002)","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — gain and loss of function with multiple molecular readouts in primary neurons, single lab","pmids":["15345706"],"is_preprint":false},{"year":2006,"finding":"Dysbindin-1 co-localizes with snapin at synaptic vesicle membranes and postsynaptic densities in mouse brain and human hippocampus. Snapin was identified as a direct binding partner of dysbindin-1 in vitro and in the brain by co-immunoprecipitation and tissue fractionation. Immunoelectron microscopy showed dysbindin-1 in synaptic vesicles of axospinous terminals and postsynaptic densities and microtubules of hippocampal neurons.","method":"Co-immunoprecipitation, tissue fractionation, immunoelectron microscopy, in vitro binding assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro binding + reciprocal co-IP + subcellular fractionation + immunoelectron microscopy; multiple orthogonal methods","pmids":["16980328"],"is_preprint":false},{"year":2006,"finding":"Within the BLOC-1 complex, dysbindin's coiled-coil region (a 69-residue segment) contains binding sites for pallidin, snapin, and muted BLOC-1 subunits. Recombinant dystrobrevin coiled-coil proteins failed to bind endogenous BLOC-1 from brain or muscle, and immunoprecipitation of endogenous dysbindin showed no co-immunoprecipitation of dystrobrevin isoforms, indicating that dysbindin assembled into BLOC-1 is not a physiological binding partner of dystrobrevins in vivo.","method":"Yeast two-hybrid, recombinant protein binding assays, co-immunoprecipitation from brain and muscle","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple binding assays with recombinant proteins + endogenous co-IP; challenges earlier model","pmids":["16448387"],"is_preprint":false},{"year":2006,"finding":"Knockdown of dysbindin expression in PC12 cells increased SNAP25 expression and dopamine release, while overexpression of dysbindin decreased SNAP25 expression, suggesting dysbindin negatively regulates dopamine release via modulation of SNAP25.","method":"siRNA knockdown, overexpression, dopamine release assay, Western blot","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — gain and loss of function in cell line with molecular readout, single lab","pmids":["16701550"],"is_preprint":false},{"year":2008,"finding":"In dysbindin-null (sdy) mice, neuroendocrine cells and hippocampal synapses exhibit specific defects in neurosecretion: larger vesicle size, slower quantal vesicle release, lower release probability, and a smaller readily releasable vesicle pool. These findings demonstrate that dysbindin functions to regulate exocytosis and vesicle biogenesis.","method":"Amperometry, whole-cell patch clamping, electron microscopy in dysbindin-null sdy mice","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 — multiple direct physiological assays (amperometry, patch clamp, EM) in genetic null model","pmids":["18504299"],"is_preprint":false},{"year":2008,"finding":"In sdy mice (dysbindin-null), steady-state levels of snapin were reduced. A 30-residue peptide in dysbindin (residues 90-119) mediates the interaction with snapin, and loss of dysbindin destabilizes snapin, suggesting dysbindin stabilizes snapin to regulate neurotransmission.","method":"Western blot in sdy mice, peptide binding assay defining interaction domain","journal":"Schizophrenia research","confidence":"Medium","confidence_rationale":"Tier 2-3 — domain mapping + protein level change in null mouse, single lab","pmids":["18774265"],"is_preprint":false},{"year":2009,"finding":"TRIM32 is an E3 ubiquitin ligase that binds and ubiquitinates dysbindin, targeting it for proteasomal degradation. TRIM32 binds dysbindin via yeast two-hybrid and augments its degradation; siRNA knockdown of TRIM32 in myoblasts elevated dysbindin levels. LGMD2H/STM-associated TRIM32 mutations (D487N and R394H) impair ubiquitin ligase activity toward dysbindin and are mislocalized; D487N binds dysbindin and its E2 enzyme but is defective in monoubiquitination.","method":"Yeast two-hybrid, co-immunoprecipitation, ubiquitination assay, siRNA knockdown, mutagenesis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro ubiquitination assay + mutagenesis + siRNA with protein level readout + multiple orthogonal methods","pmids":["19349376"],"is_preprint":false},{"year":2009,"finding":"Dysbindin regulates the surface expression of D2 dopamine receptors in cortical neurons. Loss of dysbindin (dys-/-) causes a robust increase in D2 (but not D1) receptor surface expression due to enhanced receptor recycling and insertion rather than reduced endocytosis. Dysbindin-null mice show decreased excitability of fast-spiking GABAergic interneurons in prefrontal cortex and striatum, and decreased inhibitory input to pyramidal neurons.","method":"Cell imaging, biochemical surface biotinylation, electrophysiology in dysbindin-knockout mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — imaging + biochemistry + electrophysiology in genetic knockout, multiple orthogonal methods","pmids":["19887632"],"is_preprint":false},{"year":2009,"finding":"Dysbindin controls hippocampal LTP by selectively regulating the surface expression of NMDA receptor subunit NR2A (but not NR2B). In dysbindin-null (Dys-/-) hippocampal neurons, surface NR2A expression is markedly increased, NR2A-mediated synaptic currents are enhanced, and LTP is augmented, while basal synaptic transmission, presynaptic properties, and LTD are normal. Exogenous dysbindin expression reduces NR2A surface expression.","method":"Imaging, biotinylation, electrophysiology (LTP, LTD, synaptic currents) in dysbindin-null mice, exogenous dysbindin expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (imaging, biochemistry, electrophysiology) in genetic null + rescue experiment","pmids":["19955431"],"is_preprint":false},{"year":2009,"finding":"Dysbindin is required presynaptically for retrograde homeostatic modulation of neurotransmission in Drosophila, functioning in a dose-dependent manner downstream or independently of calcium influx. Identified via electrophysiology-based forward genetic screen of >250 neuronally expressed genes.","method":"Forward genetic screen, electrophysiology at Drosophila NMJ, genetic epistasis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1-2 — unbiased forward genetic screen + electrophysiology + epistasis; highly cited","pmids":["19965435"],"is_preprint":false},{"year":2009,"finding":"Brain BLOC-1 (the dysbindin-containing complex) biochemically interacts with a subset of SNARE proteins including SNAP-25 and syntaxin 13. Primary hippocampal neurons deficient in BLOC-1 display neurite outgrowth defects, indicating a role for the dysbindin-BLOC-1 complex in neurodevelopment.","method":"Co-immunoprecipitation, primary neuron culture with BLOC-1 deficiency, neurite outgrowth assay","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP with SNARE proteins + loss-of-function neurite phenotype, single lab","pmids":["19546860"],"is_preprint":false},{"year":2009,"finding":"Dysbindin directly interacts with the mu subunit of the AP-3 adaptor protein complex, as determined by co-immunoprecipitation and direct binding assay. Dysbindin partially co-localizes with AP-3 complex in mouse hippocampus and at presynaptic terminals. Suppression of dysbindin reduces presynaptic protein expression and glutamate release.","method":"Co-immunoprecipitation, direct binding assay, siRNA knockdown, glutamate release assay","journal":"Neurochemistry international","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct binding assay + co-IP + functional knockdown; single lab","pmids":["19428785"],"is_preprint":false},{"year":2009,"finding":"Dysbindin interacts with Munc18-1 (a synaptic vesicle exocytosis regulator). Munc18-1 was co-immunoprecipitated with dysbindin from rat brain lysate and shown to directly interact with dysbindin in vitro. Part of dysbindin co-localizes with Munc18-1 at presynaptic terminals in hippocampal neurons.","method":"Affinity chromatography, mass spectrometry, co-immunoprecipitation, in vitro binding assay, co-localization","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro direct interaction + reciprocal co-IP from brain + co-localization","pmids":["19573021"],"is_preprint":false},{"year":2009,"finding":"Dysbindin promotes the post-endocytic sorting of specific GPCRs (D2 dopamine receptor, delta opioid receptor) to lysosomes. Dysbindin knockdown specifically reduced the trafficking of internalized D2 receptors to lysosomes (not endocytosis per se), increasing surface D2 expression. Dysbindin co-immunoprecipitated with GASP-1 and HRS (ESCRT component).","method":"RNA interference in HEK293 and HeLa cells, receptor trafficking assays (immunochemical, biochemical), co-immunoprecipitation","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA + mechanistic trafficking dissection + co-IP with pathway components, single lab","pmids":["20174469"],"is_preprint":false},{"year":2009,"finding":"Dysbindin engages in c-Jun N-terminal kinase (JNK) activity regulation and actin cytoskeletal organization. siRNA-mediated knockdown of dysbindin in SH-SY5Y cells caused aberrant actin cytoskeleton organization; similar morphological abnormalities were observed in growth cones of sdy mouse hippocampal neurons. Dysbindin expression level correlates with JNK phosphorylation level.","method":"siRNA knockdown, immunofluorescence for actin, Western blot for p-JNK in cell lines and primary neurons from sdy mice","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss of function in cells and mouse model with cytoskeletal readout + signaling correlation; single lab","pmids":["19094965"],"is_preprint":false},{"year":2010,"finding":"Dysbindin-1 regulates D2-receptor trafficking, and dysbindin-null (dys-/-) mice show altered CaMKII and CaMKKβ expression in medial prefrontal cortex. Dys-/- pyramidal neurons in mPFC are hyperexcitable at baseline but hypoexcitable following D2 stimulation. These effects are reproduced by chronic D2 agonist treatment.","method":"Electrophysiology, Western blot, pharmacological treatment in dysbindin-null mice","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic null model + electrophysiology + molecular readouts; follows up prior mechanistic work","pmids":["20956979"],"is_preprint":false},{"year":2010,"finding":"Dysbindin-1 forms a ternary complex with WAVE2 and Abi-1. Dysbindin-1 binds WAVE2 (but not N-WASP) as identified by co-immunoprecipitation. Dysbindin-1 promotes the binding of WAVE2 to Abi-1. siRNA knockdown of dysbindin-1 in hippocampal neurons leads to generation of abnormally elongated immature dendritic protrusions, indicating a role in dendritic spine morphogenesis.","method":"Co-immunoprecipitation, siRNA knockdown, immunofluorescence, dendritic spine morphology analysis","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP identifying complex + loss-of-function spine phenotype in primary neurons; single lab","pmids":["20531346"],"is_preprint":false},{"year":2010,"finding":"Dysbindin-1 is a nucleocytoplasmic shuttling protein with a functional nuclear export signal (NES) mediating CRM1-dependent nuclear export (blocked by leptomycin B). Nuclear shuttling of dysbindin-1 regulates synapsin I expression; in sdy (dysbindin-null) mice, synapsin I protein and mRNA levels are reduced.","method":"Nuclear export inhibition (leptomycin B), NES mutagenesis, Western blot, qPCR in sdy mice","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological + mutagenesis approach + in vivo validation in null mice; single lab","pmids":["20921223"],"is_preprint":false},{"year":2011,"finding":"Dysbindin interacts directly with DISC1 (disrupted-in-schizophrenia 1). DISC1 aggresomes recruit dysbindin in neuroblastoma cells; domains involved map to DISC1 (residues 316-597) and dysbindin (residues 82-173). A direct interaction between soluble DISC1 and dysbindin was demonstrated in a cell-free system using E. coli-expressed proteins. Co-aggregation of DISC1 and dysbindin was found in postmortem brains of a subgroup of patients with chronic mental disease.","method":"Recombinant protein interaction (cell-free), co-expression in neuroblastoma cells, domain mapping, postmortem brain biochemistry","journal":"Biological psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro direct interaction + domain mapping + cell-based + human tissue validation; single lab","pmids":["21531389"],"is_preprint":false},{"year":2011,"finding":"Dysbindin and its BLOC-1 complex sort cargo from neuronal cell bodies to the synapse. PI4KIIα copurified with BLOC-1 and AP-3 in neuronal cells; PI4KIIα content is decreased in the dentate gyrus of dysbindin-null and AP-3-null mice due to failure to traffic from the cell body. In primary cortical neurons lacking AP-3 or BLOC-1, PI4KIIα fails to reach neurites.","method":"Co-purification, Western blot in null mice, primary neuron trafficking assay, PC12 cell sorting assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — co-purification + genetic null models + primary neuron functional trafficking assay; multiple orthogonal approaches","pmids":["21998198"],"is_preprint":false},{"year":2011,"finding":"Dysbindin-1 promotes neurite outgrowth by binding necdin and recruiting it to the cytoplasm, thereby relieving necdin's repression of p53 transcriptional activity. p53 target genes coronin 1b and rab13 are required for neurite outgrowth; knockdown of dysbindin-1 reduces their expression similar to p53 knockdown. Overexpression of p53 rescues the neurite outgrowth defect caused by dysbindin-1 knockdown. In sdy mouse brains, p21, coronin 1b, and Rab13 levels are reduced.","method":"Yeast two-hybrid (necdin identification), co-immunoprecipitation, siRNA knockdown, overexpression rescue, primary cortical neuron culture from sdy mice","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — pathway placed by epistasis (p53 rescue) + binding partner identification + in vivo validation in null mice; single lab","pmids":["21502952"],"is_preprint":false},{"year":2012,"finding":"SILAC quantitative proteomics identified 24 proteins that associate with the BLOC-1 complex (containing dysbindin), including the COG complex (a Golgi apparatus tether) and antioxidant enzymes peroxiredoxins 1-2. Many of these interactors were altered in content/distribution in BLOC-1-deficient cells or tissues.","method":"SILAC quantitative proteomics, genetic analyses in dysbindin-null mice","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative proteomics + genetic null validation; identifies novel BLOC-1 interactions","pmids":["22423091"],"is_preprint":false},{"year":2011,"finding":"Drosophila dysbindin (Ddysb) regulates glutamatergic and dopaminergic functions through two independent mechanisms: reduced Ddysb in presynaptic neurons suppresses glutamatergic synaptic transmission (causing memory impairment), while reduced Ddysb in glial cells causes hyperdopaminergic activity by altering expression of dopamine metabolic enzyme Ebony (leading to abnormal locomotion and mating orientation).","method":"Cell-type-specific RNAi in Drosophila, electrophysiology, behavioral analysis, Ebony expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — cell-type-specific dissection via genetic tools, two independent mechanisms established with behavior and physiology","pmids":["22049342"],"is_preprint":false},{"year":2013,"finding":"Dysbindin-1 null mice show reduced NMDAR-dependent synaptic potentiation in CA1, which is rescued by bath application of the NMDAR co-agonist glycine (10 μM). Dysbindin-null mice also exhibit deficits in contextual fear conditioning, indicating impaired hippocampal memory processes linked to NMDAR hypofunction.","method":"Field electrophysiology in acute hippocampal slices, pharmacological rescue with glycine, fear conditioning behavioral test","journal":"Hippocampus","confidence":"Medium","confidence_rationale":"Tier 2 — electrophysiology + pharmacological rescue + behavioral test in genetic null; single lab","pmids":["24446171"],"is_preprint":false},{"year":2013,"finding":"Dysbindin-null mutant mice show decreased ready-releasable pool of synaptic vesicles, decreased quantal size, decreased release probability, and deficits in endo- and exocytosis rate in prefrontal cortical neurons. Additionally, dysbindin-null mice show decreased intracellular calcium, reduced expression of L- and N-type Ca2+ channels, and reduced levels of synaptic vesicle trafficking and priming proteins.","method":"Electrophysiology, vesicle imaging, calcium imaging, Western blot in dysbindin-null mice","journal":"Schizophrenia research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple physiological assays in genetic null model; single lab","pmids":["23473812"],"is_preprint":false},{"year":2014,"finding":"Dysbindin is required to stabilize dendritic protrusions. In dysbindin-null neurons, dendritic protrusions are hyperactive in formation, retraction, and conversion between types. This hyperactivity is attributed in part to decreased CaMKIIα activity resulting from increased inhibition of CaMKIIα by Abi1 (which accumulates when dysbindin is absent).","method":"Time-lapse imaging in hippocampal neurons, genetic null model, CaMKIIα activity assay","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — live imaging + genetic null + molecular pathway placement (Abi1-CaMKIIα); single lab","pmids":["25297099"],"is_preprint":false},{"year":2014,"finding":"Dysbindin-1C isoform (but not dysbindin-1A) is specifically localized in hilar glutamatergic mossy cells of the dentate gyrus. Dysbindin-1C deficiency leads to a decrease in mossy cells, which causes delayed maturation of newborn neurons in the dentate gyrus, indicating an isoform-specific, non-cell-autonomous role in adult hippocampal neurogenesis.","method":"Isoform-specific localization, comparison of sdy (1A+1C null) vs. muted (1A destabilized, 1C intact) mice, adult neurogenesis assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — isoform-specific localization + comparative genetic models + neurogenesis assay; single lab","pmids":["25157109"],"is_preprint":false},{"year":2015,"finding":"Dysbindin/BLOC-1 and ATP7A (copper transporter mutated in Menkes disease) genetically and biochemically interact. Loss of dysbindin/BLOC-1 alters the transcriptional profile of copper-regulatory and dependent factors in the hippocampus of null mice and alters susceptibility to toxic copper challenges in mammalian cells and Drosophila, without affecting baseline tissue copper content.","method":"Co-immunoprecipitation, genetic epistasis in Drosophila and mice, transcriptional profiling, copper toxicity assay","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical interaction + cross-species genetic epistasis + functional copper susceptibility assay","pmids":["26199316"],"is_preprint":false},{"year":2015,"finding":"Dysbindin-1 loss reduces BDNF exocytosis from cortical excitatory neurons. This reduction in BDNF exocytosis transsynaptically reduces the number of inhibitory synapses formed on excitatory neurons. Exogenous BDNF application rescues the inhibitory synaptic deficits caused by reduced dysbindin-1 in cultured and slice cultures.","method":"TIRF microscopy for BDNF exocytosis, whole-cell recordings, immunohistochemistry, pharmacological rescue in dysbindin mutant mice","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 1-2 — TIRF live imaging + electrophysiology + pharmacological rescue; multiple orthogonal methods","pmids":["26386481"],"is_preprint":false},{"year":2015,"finding":"N-ethylmaleimide-sensitive factor (NSF) is a binding partner of dysbindin/BLOC-1; NSF content is downregulated in dysbindin/BLOC-1-deficient neuroectodermal cells and iPSC-derived human neurons. Human dysbindin/BLOC-1 co-precipitates with NSF. In Drosophila, the dysbindin mutant phenotype of impaired homeostatic synaptic plasticity is fully rescued by presynaptic expression of either dysbindin or NSF.","method":"Quantitative proteomics, co-immunoprecipitation, Drosophila genetic rescue experiment, electrophysiology","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — proteomics + co-IP + in vivo genetic rescue of synaptic plasticity phenotype; multiple methods","pmids":["25972187"],"is_preprint":false},{"year":2015,"finding":"Loss of dysbindin-1 impairs hippocampal group 1 metabotropic glutamate receptor (mGluRI) function: mGluRI agonist (DHPG)-induced ERK1/2 phosphorylation is markedly reduced in sdy mouse hippocampal synaptosomes. DHPG-induced LTD at CA1 synapses is also significantly reduced. A positive allosteric modulator of mGluR5 (CDPPB) rescues short-term object recognition and spatial learning deficits in sdy mice.","method":"Synaptoneurosomes from sdy mice, Western blot for ERK1/2 phosphorylation, field electrophysiology for LTD, pharmacological rescue with CDPPB","journal":"Frontiers in behavioral neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical signaling + electrophysiology + pharmacological rescue in null mouse; single lab","pmids":["25859193"],"is_preprint":false},{"year":2015,"finding":"Drosophila BLOC-1 (containing dysbindin) is present in neurons and regulates synaptic output, morphology, and homeostatic plasticity. Homozygous loss-of-function alleles of dysb or Blos1, or compound heterozygotes, impair neurotransmitter release, synapse morphology, and homeostatic plasticity at the larval NMJ and impair olfactory habituation. Phenotypes are differentially sensitive to genetic dosage of BLOC-1 alleles.","method":"Drosophila genetics, electrophysiology at NMJ, behavioral assay, biochemical confirmation of BLOC-1 in neurons","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — genetic dosage analysis + electrophysiology + behavior in Drosophila model; single lab","pmids":["25568125"],"is_preprint":false},{"year":2016,"finding":"The Arp2/3 actin polymerization complex is identified downstream of dysbindin/BLOC-1 by quantitative proteomics; Arp2/3 subunits are downregulated by BLOC-1 loss of function. Arp2/3, dysbindin, and BLOC-1 subunits biochemically and genetically interact, modulating Drosophila synapse morphology and homeostatic plasticity. Loss of BLOC-1 affects actin dynamics in early endosomes.","method":"Quantitative mass spectrometry, co-immunoprecipitation, genetic interaction in Drosophila, actin dynamics assay","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — quantitative proteomics + co-IP + cross-species genetic validation + functional actin assay; multiple methods","pmids":["27927957"],"is_preprint":false},{"year":2017,"finding":"TRIM24 is identified as a novel dysbindin binding partner in cardiac muscle (yeast two-hybrid + co-immunoprecipitation). TRIM24 protects dysbindin from TRIM32-mediated ubiquitin-dependent degradation, promoting SRF-dependent hypertrophic signaling. TRIM32 degrades dysbindin in cardiomyocytes and also promotes apoptosis via p53 and caspase-3/-7 activation.","method":"Yeast two-hybrid, co-immunoprecipitation, co-immunostaining, overexpression/knockdown in neonatal cardiomyocytes, SRF reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — yeast two-hybrid + co-IP + functional overexpression assay; single lab","pmids":["28465353"],"is_preprint":false},{"year":2018,"finding":"Genetic variations reducing dysbindin-1 expression interact with antipsychotic drugs to improve executive functions in schizophrenia. The molecular mechanism involves an imbalance between short and long isoforms of dopamine D2 receptors, leading to enhanced presynaptic D2 function in the prefrontal cortex, as demonstrated in postmortem human brains and dysbindin-deficient mice treated with antipsychotics.","method":"Postmortem human brain analysis (D2R isoforms), genetically modified mice, pharmacological treatment, ex vivo and in vivo analyses","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — human postmortem + mouse genetic model + pharmacological intervention; single lab","pmids":["29891954"],"is_preprint":false},{"year":2015,"finding":"Dysbindin-1B aggregates into cell-invasive deposits and propagates between neurons via exosome-mediated transmission. Dysbindin-1B aggregates are neurotoxic and exert toxic effects on recipient neurons distant from the initial aggregation site through exosomal spread in mouse brain.","method":"Overexpression in mice, exosome isolation, neuronal toxicity assay, live imaging","journal":"Neuroscience","confidence":"Low","confidence_rationale":"Tier 3 — single lab, isoform-specific aggregation with exosome mechanism; limited mechanistic follow-up","pmids":["25704251"],"is_preprint":false}],"current_model":"Dysbindin (DTNBP1) is a coiled-coil protein that assembles as a core subunit of the octameric BLOC-1 complex, which mediates vesicle trafficking from endosomes to lysosome-related organelles and from neuronal cell bodies to synapses via interaction with AP-3; at the presynapse, dysbindin regulates synaptic vesicle biogenesis, the size of the readily releasable pool, and exocytosis (including glutamate and BDNF release), and is required for homeostatic synaptic plasticity; postsynaptically, it controls NR2A surface expression to modulate LTP, and regulates D2 dopamine receptor trafficking to lysosomes, thereby influencing GABAergic interneuron excitability and prefrontal cortical function; dysbindin protein levels are regulated by TRIM32 (E3 ubiquitin ligase) and TRIM24 (protective against TRIM32-mediated degradation), and the protein shuttles between cytoplasm and nucleus where it controls synapsin I expression."},"narrative":{"teleology":[{"year":2001,"claim":"The initial identification of dysbindin as a dystrobrevin-binding coiled-coil protein established it as a component of the dystrophin-associated protein complex in muscle and brain, localizing it to synaptic terminals.","evidence":"Yeast two-hybrid, reciprocal co-immunoprecipitation, and immunofluorescence in muscle and brain tissue","pmids":["11316798"],"confidence":"High","gaps":["Functional consequence of the dystrobrevin interaction was unknown","Whether dysbindin operated independently of the DPC was unresolved"]},{"year":2003,"claim":"Discovery that dysbindin is an obligate subunit of BLOC-1 and that its loss causes Hermansky-Pudlak syndrome type 7 reframed dysbindin from a DPC component to a vesicle trafficking regulator, and later work showed BLOC-1-assembled dysbindin does not physiologically bind dystrobrevins.","evidence":"Sandy (sdy) mouse model, human HPS-7 mutation analysis, BLOC-1 complex identification; subsequently challenged by recombinant protein and endogenous co-IP experiments","pmids":["12923531","16448387"],"confidence":"High","gaps":["Specific vesicle trafficking step controlled by dysbindin-BLOC-1 was not defined","Brain-specific vs. ubiquitous function of BLOC-1 was unclear"]},{"year":2004,"claim":"Gain- and loss-of-function studies in cortical neurons established that dysbindin positively regulates presynaptic protein expression (SNAP25, synapsin I) and glutamate release, linking it to excitatory neurotransmission and PI3K-Akt survival signaling.","evidence":"Overexpression and siRNA knockdown in primary cortical neurons with glutamate release assays and Akt phosphorylation readouts","pmids":["15345706"],"confidence":"Medium","gaps":["Direction of SNAP25 regulation was contradicted by PC12 cell data (PMID:16701550)","Whether glutamate release effects were cell-autonomous was untested"]},{"year":2006,"claim":"Identification of snapin as a direct synaptic vesicle-associated partner of dysbindin, with immunoelectron microscopy placing dysbindin at synaptic vesicles and postsynaptic densities, provided ultrastructural evidence for its dual pre- and postsynaptic roles.","evidence":"In vitro binding, reciprocal co-IP, subcellular fractionation, and immunoelectron microscopy in mouse hippocampus","pmids":["16980328"],"confidence":"High","gaps":["Functional consequence of the dysbindin-snapin interaction on vesicle release was not tested"]},{"year":2008,"claim":"Electrophysiological and ultrastructural analysis of dysbindin-null mice revealed that dysbindin is required for normal vesicle biogenesis, quantal size, release probability, and readily releasable pool size, establishing its direct role in regulated exocytosis.","evidence":"Amperometry, whole-cell patch clamp, and electron microscopy in sdy mouse neuroendocrine cells and hippocampal synapses","pmids":["18504299"],"confidence":"High","gaps":["Molecular intermediates between BLOC-1 and vesicle biogenesis machinery were unknown","Whether defects were BLOC-1-dependent was not resolved"]},{"year":2009,"claim":"A convergent set of 2009 studies defined dysbindin's postsynaptic functions: it controls surface expression of D2 dopamine receptors (via post-endocytic lysosomal sorting) and NR2A-containing NMDA receptors, thereby modulating GABAergic interneuron excitability and hippocampal LTP, respectively. Concurrently, a Drosophila forward genetic screen established dysbindin as essential for presynaptic homeostatic synaptic plasticity.","evidence":"Surface biotinylation, receptor trafficking, and electrophysiology in dys−/− mice (D2R and NR2A); unbiased electrophysiology-based screen plus epistasis at Drosophila NMJ","pmids":["19887632","19955431","19965435","20174469"],"confidence":"High","gaps":["Mechanism by which dysbindin directs receptor-specific sorting remained unclear","Identity of the calcium-independent step in homeostatic plasticity was not resolved"]},{"year":2009,"claim":"TRIM32 was identified as the E3 ubiquitin ligase that ubiquitinates and targets dysbindin for proteasomal degradation, with LGMD2H-associated TRIM32 mutations impairing this activity, connecting dysbindin turnover to muscle disease.","evidence":"Yeast two-hybrid, in vitro ubiquitination assay, siRNA knockdown in myoblasts, mutagenesis of disease-associated TRIM32 alleles","pmids":["19349376"],"confidence":"High","gaps":["Whether TRIM32-mediated regulation of dysbindin occurs in neurons was untested","Physiological consequence of elevated dysbindin in TRIM32 mutant muscle was not shown"]},{"year":2009,"claim":"Direct interactions of BLOC-1/dysbindin with AP-3 adaptor, SNARE proteins (SNAP-25, syntaxin 13), and Munc18-1 placed the complex within the molecular machinery of vesicle sorting and fusion, and revealed neurite outgrowth as a BLOC-1-dependent developmental process.","evidence":"Co-immunoprecipitation, direct binding assays, affinity chromatography/mass spectrometry, neurite outgrowth assays in BLOC-1-deficient neurons","pmids":["19546860","19428785","19573021"],"confidence":"Medium","gaps":["Hierarchy among AP-3, SNARE, and Munc18-1 interactions was not established","Whether neurite outgrowth defects are BLOC-1-specific or a general SNARE trafficking phenotype was unclear"]},{"year":2010,"claim":"Dysbindin was found to undergo CRM1-dependent nucleocytoplasmic shuttling and to regulate synapsin I transcription from the nucleus, revealing a non-canonical nuclear function beyond vesicle trafficking.","evidence":"Leptomycin B treatment, NES mutagenesis, qPCR and Western blot for synapsin I in sdy mice","pmids":["20921223"],"confidence":"Medium","gaps":["The transcription factor(s) or chromatin targets mediating synapsin I regulation were not identified","Fraction of dysbindin in nucleus vs. cytoplasm under physiological conditions was not quantified"]},{"year":2011,"claim":"BLOC-1/AP-3-dependent sorting was shown to deliver specific cargo (PI4KIIα) from neuronal cell bodies to synapses, providing a concrete example of how dysbindin-containing BLOC-1 controls synaptic protein composition.","evidence":"Co-purification of PI4KIIα with BLOC-1/AP-3, reduced PI4KIIα in dentate gyrus of dysbindin-null and AP-3-null mice, neurite trafficking assay","pmids":["21998198"],"confidence":"High","gaps":["Full repertoire of BLOC-1/AP-3-dependent synaptic cargoes was not defined","Whether PI4KIIα loss accounts for synaptic vesicle biogenesis defects was unknown"]},{"year":2015,"claim":"NSF was identified as a key effector downstream of dysbindin/BLOC-1: NSF is downregulated by BLOC-1 deficiency, and presynaptic NSF expression fully rescues the homeostatic plasticity defect in Drosophila dysbindin mutants, establishing a mechanistic link between BLOC-1 and SNARE-dependent membrane fusion.","evidence":"Quantitative proteomics, co-immunoprecipitation, genetic rescue experiment with electrophysiology at Drosophila NMJ","pmids":["25972187"],"confidence":"High","gaps":["Whether NSF rescue reflects restored vesicle fusion per se or secondary effects on vesicle pools was not distinguished","Mammalian validation of the NSF rescue was lacking"]},{"year":2015,"claim":"TIRF microscopy demonstrated that dysbindin loss specifically reduces BDNF exocytosis from excitatory neurons, which transsynaptically decreases inhibitory synapse formation — a circuit-level mechanism linking dysbindin to excitatory-inhibitory balance.","evidence":"TIRF live imaging of BDNF vesicle fusion, electrophysiology, immunohistochemistry, and BDNF rescue in dysbindin mutant cortical neurons and slices","pmids":["26386481"],"confidence":"High","gaps":["Whether BDNF exocytosis defect is BLOC-1-dependent or involves a BLOC-1-independent dysbindin function was not resolved"]},{"year":2016,"claim":"The Arp2/3 actin polymerization complex was placed downstream of BLOC-1 as a regulator of endosomal actin dynamics, synapse morphology, and homeostatic plasticity, integrating dysbindin's vesicle trafficking function with actin cytoskeletal remodeling.","evidence":"Quantitative mass spectrometry, co-immunoprecipitation, Drosophila genetic interaction, endosomal actin dynamics assay","pmids":["27927957"],"confidence":"High","gaps":["Direct vs. indirect regulation of Arp2/3 by BLOC-1 was not resolved","How Arp2/3-dependent actin remodeling connects to vesicle biogenesis defects was untested"]},{"year":2017,"claim":"TRIM24 was identified as a protective factor that counteracts TRIM32-mediated degradation of dysbindin in cardiomyocytes, linking dysbindin stability to SRF-dependent hypertrophic signaling in the heart.","evidence":"Yeast two-hybrid, co-immunoprecipitation, overexpression/knockdown in neonatal cardiomyocytes, SRF reporter assay","pmids":["28465353"],"confidence":"Medium","gaps":["Whether TRIM24-TRIM32 competition for dysbindin occurs in neurons was not tested","Structural basis for competitive binding was not defined"]},{"year":null,"claim":"Key unresolved questions include: the full cargo repertoire of BLOC-1/AP-3-dependent sorting in neurons; the transcriptional mechanism by which nuclear dysbindin regulates synapsin I; whether BLOC-1-dependent and BLOC-1-independent functions of dysbindin can be cleanly separated in vivo; and the structural basis for dysbindin's assembly into BLOC-1 and its interaction with diverse partners.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of dysbindin or BLOC-1 with dysbindin","Nuclear transcriptional targets beyond synapsin I are undefined","Separation of BLOC-1-dependent vs. independent functions in mammalian neurons not achieved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,14,22]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[19,35]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,20]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[20]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4,7,22]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[16,35]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,7,14,22]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,36]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[10,11,12,31]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[10,11,33]}],"complexes":["BLOC-1"],"partners":["PLDN","SNAPIN","MUTED","AP3B1","TRIM32","TRIM24","NSF","MUNC18-1"],"other_free_text":[]},"mechanistic_narrative":"DTNBP1 (dysbindin) is a coiled-coil protein that functions as a core subunit of the BLOC-1 complex to regulate vesicle trafficking from endosomes to lysosome-related organelles and from neuronal cell bodies to synapses, with loss-of-function mutations causing Hermansky-Pudlak syndrome type 7 [PMID:12923531]. At the presynapse, dysbindin controls synaptic vesicle biogenesis, the size of the readily releasable pool, quantal release, and exocytosis of glutamate and BDNF, and is required for homeostatic synaptic plasticity through a mechanism involving NSF and acting downstream or independently of calcium influx [PMID:18504299, PMID:19965435, PMID:25972187, PMID:26386481]. Postsynaptically, dysbindin regulates surface expression of NR2A-containing NMDA receptors to modulate LTP and directs D2 dopamine receptor sorting to lysosomes, thereby controlling GABAergic interneuron excitability in prefrontal cortex [PMID:19955431, PMID:19887632]. Dysbindin protein levels are regulated by TRIM32-mediated ubiquitin-dependent degradation counteracted by TRIM24, and dysbindin undergoes CRM1-dependent nucleocytoplasmic shuttling to control synapsin I transcription [PMID:19349376, PMID:28465353, PMID:20921223]."},"prefetch_data":{"uniprot":{"accession":"Q96EV8","full_name":"Dysbindin","aliases":["Biogenesis of lysosome-related organelles complex 1 subunit 8","BLOC-1 subunit 8","Dysbindin-1","Dystrobrevin-binding protein 1","Hermansky-Pudlak syndrome 7 protein","HPS7 protein"],"length_aa":351,"mass_kda":39.5,"function":"Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway","subcellular_location":"Cytoplasm; Cytoplasmic vesicle membrane; Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Endosome membrane; Melanosome membrane; Postsynaptic cell membrane; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q96EV8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DTNBP1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DTNBP1","total_profiled":1310},"omim":[{"mim_id":"620388","title":"DYSBINDIN DOMAIN-CONTAINING PROTEIN 1; DBNDD1","url":"https://www.omim.org/entry/620388"},{"mim_id":"620098","title":"DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES; DIDDF","url":"https://www.omim.org/entry/620098"},{"mim_id":"615178","title":"KXDL MOTIF-CONTAINING PROTEIN 1; KXD1","url":"https://www.omim.org/entry/615178"},{"mim_id":"614076","title":"HERMANSKY-PUDLAK SYNDROME 7; HPS7","url":"https://www.omim.org/entry/614076"},{"mim_id":"612193","title":"CARDIOMYOPATHY-ASSOCIATED PROTEIN 5; CMYA5","url":"https://www.omim.org/entry/612193"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Microtubules","reliability":"Enhanced"},{"location":"Midbody","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":89.8},{"tissue":"retina","ntpm":117.7}],"url":"https://www.proteinatlas.org/search/DTNBP1"},"hgnc":{"alias_symbol":["Dysbindin","My031","HPS7","DBND","BLOC1S8"],"prev_symbol":[]},"alphafold":{"accession":"Q96EV8","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EV8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EV8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EV8-F1-predicted_aligned_error_v6.png","plddt_mean":74.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DTNBP1","jax_strain_url":"https://www.jax.org/strain/search?query=DTNBP1"},"sequence":{"accession":"Q96EV8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96EV8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96EV8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EV8"}},"corpus_meta":[{"pmid":"12923531","id":"PMC_12923531","title":"Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1).","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12923531","citation_count":352,"is_preprint":false},{"pmid":"12474144","id":"PMC_12474144","title":"Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families.","date":"2002","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12474144","citation_count":291,"is_preprint":false},{"pmid":"15345706","id":"PMC_15345706","title":"Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.","date":"2004","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15345706","citation_count":280,"is_preprint":false},{"pmid":"11316798","id":"PMC_11316798","title":"Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11316798","citation_count":254,"is_preprint":false},{"pmid":"19965435","id":"PMC_19965435","title":"The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.","date":"2009","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/19965435","citation_count":179,"is_preprint":false},{"pmid":"14618545","id":"PMC_14618545","title":"The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.","date":"2003","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14618545","citation_count":160,"is_preprint":false},{"pmid":"15066891","id":"PMC_15066891","title":"Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).","date":"2004","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15066891","citation_count":147,"is_preprint":false},{"pmid":"15362017","id":"PMC_15362017","title":"Association of the DTNBP1 locus with schizophrenia in a U.S. population.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15362017","citation_count":134,"is_preprint":false},{"pmid":"16415041","id":"PMC_16415041","title":"Genetic variation in DTNBP1 influences general cognitive ability.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16415041","citation_count":134,"is_preprint":false},{"pmid":"18504299","id":"PMC_18504299","title":"DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18504299","citation_count":128,"is_preprint":false},{"pmid":"16980328","id":"PMC_16980328","title":"Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin.","date":"2006","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16980328","citation_count":127,"is_preprint":false},{"pmid":"19887632","id":"PMC_19887632","title":"Role of dysbindin in dopamine receptor trafficking and cortical GABA function.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19887632","citation_count":125,"is_preprint":false},{"pmid":"19546860","id":"PMC_19546860","title":"The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.","date":"2009","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19546860","citation_count":124,"is_preprint":false},{"pmid":"12808430","id":"PMC_12808430","title":"Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families.","date":"2003","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12808430","citation_count":118,"is_preprint":false},{"pmid":"20956979","id":"PMC_20956979","title":"Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20956979","citation_count":116,"is_preprint":false},{"pmid":"19349376","id":"PMC_19349376","title":"TRIM32 is an E3 ubiquitin ligase for dysbindin.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19349376","citation_count":112,"is_preprint":false},{"pmid":"17961984","id":"PMC_17961984","title":"Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17961984","citation_count":110,"is_preprint":false},{"pmid":"18774265","id":"PMC_18774265","title":"Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia.","date":"2008","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/18774265","citation_count":105,"is_preprint":false},{"pmid":"19617633","id":"PMC_19617633","title":"Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19617633","citation_count":98,"is_preprint":false},{"pmid":"18945333","id":"PMC_18945333","title":"Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.","date":"2008","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/18945333","citation_count":98,"is_preprint":false},{"pmid":"19955431","id":"PMC_19955431","title":"Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19955431","citation_count":86,"is_preprint":false},{"pmid":"19220483","id":"PMC_19220483","title":"Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19220483","citation_count":85,"is_preprint":false},{"pmid":"16166606","id":"PMC_16166606","title":"Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?","date":"2005","source":"Schizophrenia bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/16166606","citation_count":81,"is_preprint":false},{"pmid":"18555792","id":"PMC_18555792","title":"Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18555792","citation_count":81,"is_preprint":false},{"pmid":"20531346","id":"PMC_20531346","title":"Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation.","date":"2010","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20531346","citation_count":81,"is_preprint":false},{"pmid":"19641486","id":"PMC_19641486","title":"Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.","date":"2009","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19641486","citation_count":79,"is_preprint":false},{"pmid":"15820225","id":"PMC_15820225","title":"Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1).","date":"2005","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15820225","citation_count":77,"is_preprint":false},{"pmid":"22423091","id":"PMC_22423091","title":"Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22423091","citation_count":74,"is_preprint":false},{"pmid":"12591580","id":"PMC_12591580","title":"No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study.","date":"2003","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/12591580","citation_count":73,"is_preprint":false},{"pmid":"16407900","id":"PMC_16407900","title":"DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals.","date":"2006","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16407900","citation_count":72,"is_preprint":false},{"pmid":"17033966","id":"PMC_17033966","title":"Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.","date":"2006","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17033966","citation_count":71,"is_preprint":false},{"pmid":"17408693","id":"PMC_17408693","title":"Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction.","date":"2007","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17408693","citation_count":67,"is_preprint":false},{"pmid":"16283082","id":"PMC_16283082","title":"Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS).","date":"2005","source":"Journal of autism and developmental disorders","url":"https://pubmed.ncbi.nlm.nih.gov/16283082","citation_count":65,"is_preprint":false},{"pmid":"21520000","id":"PMC_21520000","title":"Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.","date":"2011","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21520000","citation_count":64,"is_preprint":false},{"pmid":"21531389","id":"PMC_21531389","title":"Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21531389","citation_count":64,"is_preprint":false},{"pmid":"18984010","id":"PMC_18984010","title":"Behavioral characterization of dysbindin-1 deficient sandy mice.","date":"2008","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18984010","citation_count":64,"is_preprint":false},{"pmid":"21504412","id":"PMC_21504412","title":"Dysbindin-containing complexes and their proposed functions in brain: from zero to (too) many in a decade.","date":"2011","source":"ASN neuro","url":"https://pubmed.ncbi.nlm.nih.gov/21504412","citation_count":62,"is_preprint":false},{"pmid":"12878699","id":"PMC_12878699","title":"Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12878699","citation_count":62,"is_preprint":false},{"pmid":"21998198","id":"PMC_21998198","title":"The schizophrenia susceptibility factor dysbindin and its associated complex sort cargoes from cell bodies to the synapse.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21998198","citation_count":61,"is_preprint":false},{"pmid":"16701550","id":"PMC_16701550","title":"Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16701550","citation_count":61,"is_preprint":false},{"pmid":"16448387","id":"PMC_16448387","title":"Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16448387","citation_count":60,"is_preprint":false},{"pmid":"20174469","id":"PMC_20174469","title":"Dysbindin promotes the post-endocytic sorting of G protein-coupled receptors to lysosomes.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20174469","citation_count":56,"is_preprint":false},{"pmid":"24145376","id":"PMC_24145376","title":"Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans.","date":"2013","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/24145376","citation_count":55,"is_preprint":false},{"pmid":"14688250","id":"PMC_14688250","title":"Myospryn is a novel binding partner for dysbindin in muscle.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14688250","citation_count":55,"is_preprint":false},{"pmid":"20302821","id":"PMC_20302821","title":"The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research.","date":"2009","source":"Progress in brain research","url":"https://pubmed.ncbi.nlm.nih.gov/20302821","citation_count":54,"is_preprint":false},{"pmid":"17945199","id":"PMC_17945199","title":"Early visual processing deficits in dysbindin-associated schizophrenia.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17945199","citation_count":53,"is_preprint":false},{"pmid":"21502952","id":"PMC_21502952","title":"Dysbindin-1, a schizophrenia-related protein, facilitates neurite outgrowth by promoting the transcriptional activity of p53.","date":"2011","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21502952","citation_count":51,"is_preprint":false},{"pmid":"16044171","id":"PMC_16044171","title":"Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.","date":"2005","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16044171","citation_count":48,"is_preprint":false},{"pmid":"17618940","id":"PMC_17618940","title":"Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17618940","citation_count":48,"is_preprint":false},{"pmid":"27091610","id":"PMC_27091610","title":"COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.","date":"2016","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27091610","citation_count":47,"is_preprint":false},{"pmid":"17300918","id":"PMC_17300918","title":"The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17300918","citation_count":46,"is_preprint":false},{"pmid":"22049342","id":"PMC_22049342","title":"Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22049342","citation_count":45,"is_preprint":false},{"pmid":"25568125","id":"PMC_25568125","title":"Gene dosage in the dysbindin schizophrenia susceptibility network differentially affect synaptic function and plasticity.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25568125","citation_count":44,"is_preprint":false},{"pmid":"17555717","id":"PMC_17555717","title":"The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17555717","citation_count":43,"is_preprint":false},{"pmid":"19077176","id":"PMC_19077176","title":"Variation in the dysbindin gene and normal cognitive function in three independent population samples.","date":"2008","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19077176","citation_count":42,"is_preprint":false},{"pmid":"16946192","id":"PMC_16946192","title":"Association of the dysbindin gene with bipolar affective disorder.","date":"2006","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16946192","citation_count":41,"is_preprint":false},{"pmid":"29891954","id":"PMC_29891954","title":"Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29891954","citation_count":40,"is_preprint":false},{"pmid":"28465353","id":"PMC_28465353","title":"TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28465353","citation_count":39,"is_preprint":false},{"pmid":"17290445","id":"PMC_17290445","title":"Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17290445","citation_count":38,"is_preprint":false},{"pmid":"19094965","id":"PMC_19094965","title":"Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19094965","citation_count":37,"is_preprint":false},{"pmid":"28937620","id":"PMC_28937620","title":"Dysbindin-1 Involvement in the Etiology of Schizophrenia.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28937620","citation_count":37,"is_preprint":false},{"pmid":"19650139","id":"PMC_19650139","title":"Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals.","date":"2010","source":"Human brain mapping","url":"https://pubmed.ncbi.nlm.nih.gov/19650139","citation_count":37,"is_preprint":false},{"pmid":"19782967","id":"PMC_19782967","title":"Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia.","date":"2009","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19782967","citation_count":35,"is_preprint":false},{"pmid":"20236384","id":"PMC_20236384","title":"Cytosolic protein interactions of the schizophrenia susceptibility gene dysbindin.","date":"2010","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20236384","citation_count":34,"is_preprint":false},{"pmid":"19439994","id":"PMC_19439994","title":"DTNBP1, NRG1, DAOA, DAO and GRM3 polymorphisms and schizophrenia: an association study.","date":"2009","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/19439994","citation_count":31,"is_preprint":false},{"pmid":"19089808","id":"PMC_19089808","title":"Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19089808","citation_count":31,"is_preprint":false},{"pmid":"15331232","id":"PMC_15331232","title":"Schizophrenia genetics: dysbindin under the microscope.","date":"2004","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/15331232","citation_count":31,"is_preprint":false},{"pmid":"19800201","id":"PMC_19800201","title":"The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.","date":"2009","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/19800201","citation_count":31,"is_preprint":false},{"pmid":"20045719","id":"PMC_20045719","title":"Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20045719","citation_count":31,"is_preprint":false},{"pmid":"24713699","id":"PMC_24713699","title":"Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24713699","citation_count":30,"is_preprint":false},{"pmid":"16876895","id":"PMC_16876895","title":"Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population.","date":"2006","source":"Neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/16876895","citation_count":30,"is_preprint":false},{"pmid":"26386481","id":"PMC_26386481","title":"Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1.","date":"2015","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26386481","citation_count":30,"is_preprint":false},{"pmid":"21130223","id":"PMC_21130223","title":"Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.","date":"2010","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/21130223","citation_count":29,"is_preprint":false},{"pmid":"20615671","id":"PMC_20615671","title":"Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.","date":"2010","source":"European psychiatry : the journal of the Association of European Psychiatrists","url":"https://pubmed.ncbi.nlm.nih.gov/20615671","citation_count":29,"is_preprint":false},{"pmid":"25972187","id":"PMC_25972187","title":"The N-ethylmaleimide-sensitive factor and dysbindin interact to modulate synaptic plasticity.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25972187","citation_count":28,"is_preprint":false},{"pmid":"24446171","id":"PMC_24446171","title":"Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.","date":"2013","source":"Hippocampus","url":"https://pubmed.ncbi.nlm.nih.gov/24446171","citation_count":28,"is_preprint":false},{"pmid":"17604607","id":"PMC_17604607","title":"Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: a meta-analysis.","date":"2007","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/17604607","citation_count":28,"is_preprint":false},{"pmid":"18314870","id":"PMC_18314870","title":"Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18314870","citation_count":28,"is_preprint":false},{"pmid":"27927957","id":"PMC_27927957","title":"The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27927957","citation_count":27,"is_preprint":false},{"pmid":"23473812","id":"PMC_23473812","title":"Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice.","date":"2013","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/23473812","citation_count":27,"is_preprint":false},{"pmid":"19497374","id":"PMC_19497374","title":"Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals.","date":"2009","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/19497374","citation_count":27,"is_preprint":false},{"pmid":"25297099","id":"PMC_25297099","title":"The schizophrenia susceptibility gene dysbindin regulates dendritic spine dynamics.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25297099","citation_count":26,"is_preprint":false},{"pmid":"19428785","id":"PMC_19428785","title":"Direct interaction of Dysbindin with the AP-3 complex via its mu subunit.","date":"2009","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/19428785","citation_count":26,"is_preprint":false},{"pmid":"25859193","id":"PMC_25859193","title":"Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice.","date":"2015","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25859193","citation_count":26,"is_preprint":false},{"pmid":"17192893","id":"PMC_17192893","title":"Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17192893","citation_count":25,"is_preprint":false},{"pmid":"25157109","id":"PMC_25157109","title":"Dysbindin-1C is required for the survival of hilar mossy cells and the maturation of adult newborn neurons in dentate gyrus.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25157109","citation_count":25,"is_preprint":false},{"pmid":"26199316","id":"PMC_26199316","title":"Neuronal copper homeostasis susceptibility by genetic defects in dysbindin, a schizophrenia susceptibility factor.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26199316","citation_count":25,"is_preprint":false},{"pmid":"19573021","id":"PMC_19573021","title":"Proteomic analysis reveals novel binding partners of dysbindin, a schizophrenia-related protein.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19573021","citation_count":25,"is_preprint":false},{"pmid":"19496996","id":"PMC_19496996","title":"Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects.","date":"2009","source":"Psychiatry and clinical neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/19496996","citation_count":25,"is_preprint":false},{"pmid":"23364359","id":"PMC_23364359","title":"Microsatellite markers as a rapid approach for autozygosity mapping in Hermansky-Pudlak syndrome: identification of the second HPS7 mutation in a patient presenting late in life.","date":"2013","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/23364359","citation_count":24,"is_preprint":false},{"pmid":"19369910","id":"PMC_19369910","title":"The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19369910","citation_count":23,"is_preprint":false},{"pmid":"25697573","id":"PMC_25697573","title":"Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia.","date":"2015","source":"European psychiatry : the journal of the Association of European Psychiatrists","url":"https://pubmed.ncbi.nlm.nih.gov/25697573","citation_count":23,"is_preprint":false},{"pmid":"19065121","id":"PMC_19065121","title":"Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19065121","citation_count":23,"is_preprint":false},{"pmid":"20921223","id":"PMC_20921223","title":"Nucleocytoplasmic shuttling of dysbindin-1, a schizophrenia-related protein, regulates synapsin I expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20921223","citation_count":22,"is_preprint":false},{"pmid":"25677649","id":"PMC_25677649","title":"Constant light uncovers behavioral effects of a mutation in the schizophrenia risk gene Dtnbp1 in mice.","date":"2015","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/25677649","citation_count":22,"is_preprint":false},{"pmid":"16959423","id":"PMC_16959423","title":"The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16959423","citation_count":22,"is_preprint":false},{"pmid":"19353385","id":"PMC_19353385","title":"A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.","date":"2010","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19353385","citation_count":21,"is_preprint":false},{"pmid":"21305691","id":"PMC_21305691","title":"Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.","date":"2011","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21305691","citation_count":21,"is_preprint":false},{"pmid":"25704251","id":"PMC_25704251","title":"Propagation of dysbindin-1B aggregates: exosome-mediated transmission of neurotoxic deposits.","date":"2015","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25704251","citation_count":21,"is_preprint":false},{"pmid":"30230404","id":"PMC_30230404","title":"Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.","date":"2018","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30230404","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47903,"output_tokens":9828,"usd":0.145565},"stage2":{"model":"claude-opus-4-6","input_tokens":13693,"output_tokens":3883,"usd":0.24831},"total_usd":0.393875,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Dysbindin (DTNBP1) was identified as a novel coiled-coil-containing protein that binds directly to alpha- and beta-dystrobrevin in muscle and brain via yeast two-hybrid screen; dystrophin and alpha-dystrobrevin are co-immunoprecipitated with dysbindin, indicating dysbindin is a component of the dystrophin-associated protein complex (DPC). In brain, dysbindin localizes primarily to axon bundles and mossy fiber synaptic terminals in the cerebellum and hippocampus.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, co-localization by immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original identification with yeast two-hybrid, reciprocal co-IP, and localization; strong foundational study\",\n      \"pmids\": [\"11316798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Dysbindin is a component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1), which includes pallidin, muted, and cappuccino. Mutant sandy (sdy) mice lack dysbindin protein due to a deletion in Dtnbp1, and mutations in human DTNBP1 cause Hermansky-Pudlak syndrome type 7 (HPS-7), demonstrating dysbindin's role in vesicle trafficking to lysosome-related organelles such as melanosomes and platelet dense granules.\",\n      \"method\": \"Mouse genetic deletion model, protein complex identification, human mutation analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic null model + human disease mutation + complex identification; highly cited foundational paper\",\n      \"pmids\": [\"12923531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Dysbindin binds to myospryn, a novel 413-kDa protein expressed in cardiac and skeletal muscle. Dysbindin and myospryn co-immunoprecipitate from muscle extracts and are extensively co-localized, identifying a tissue-specific ligand for dysbindin in muscle.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, co-localization by immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — yeast two-hybrid + reciprocal co-IP + co-localization, single lab\",\n      \"pmids\": [\"14688250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Overexpression of dysbindin in primary cortical neurons increased expression of pre-synaptic proteins SNAP25 and synapsin I, and increased extracellular basal glutamate levels and evoked glutamate release. Conversely, siRNA-mediated knockdown reduced pre-synaptic protein expression and glutamate release, indicating dysbindin influences exocytotic glutamate release. Dysbindin overexpression also increased Akt phosphorylation and protected neurons against death via PI3-kinase-Akt signaling; siRNA knockdown diminished Akt phosphorylation and facilitated neuronal death.\",\n      \"method\": \"Neuronal overexpression, siRNA knockdown, glutamate release assay, Western blot for Akt phosphorylation, pharmacological inhibition (LY294002)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain and loss of function with multiple molecular readouts in primary neurons, single lab\",\n      \"pmids\": [\"15345706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dysbindin-1 co-localizes with snapin at synaptic vesicle membranes and postsynaptic densities in mouse brain and human hippocampus. Snapin was identified as a direct binding partner of dysbindin-1 in vitro and in the brain by co-immunoprecipitation and tissue fractionation. Immunoelectron microscopy showed dysbindin-1 in synaptic vesicles of axospinous terminals and postsynaptic densities and microtubules of hippocampal neurons.\",\n      \"method\": \"Co-immunoprecipitation, tissue fractionation, immunoelectron microscopy, in vitro binding assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding + reciprocal co-IP + subcellular fractionation + immunoelectron microscopy; multiple orthogonal methods\",\n      \"pmids\": [\"16980328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Within the BLOC-1 complex, dysbindin's coiled-coil region (a 69-residue segment) contains binding sites for pallidin, snapin, and muted BLOC-1 subunits. Recombinant dystrobrevin coiled-coil proteins failed to bind endogenous BLOC-1 from brain or muscle, and immunoprecipitation of endogenous dysbindin showed no co-immunoprecipitation of dystrobrevin isoforms, indicating that dysbindin assembled into BLOC-1 is not a physiological binding partner of dystrobrevins in vivo.\",\n      \"method\": \"Yeast two-hybrid, recombinant protein binding assays, co-immunoprecipitation from brain and muscle\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple binding assays with recombinant proteins + endogenous co-IP; challenges earlier model\",\n      \"pmids\": [\"16448387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Knockdown of dysbindin expression in PC12 cells increased SNAP25 expression and dopamine release, while overexpression of dysbindin decreased SNAP25 expression, suggesting dysbindin negatively regulates dopamine release via modulation of SNAP25.\",\n      \"method\": \"siRNA knockdown, overexpression, dopamine release assay, Western blot\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain and loss of function in cell line with molecular readout, single lab\",\n      \"pmids\": [\"16701550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In dysbindin-null (sdy) mice, neuroendocrine cells and hippocampal synapses exhibit specific defects in neurosecretion: larger vesicle size, slower quantal vesicle release, lower release probability, and a smaller readily releasable vesicle pool. These findings demonstrate that dysbindin functions to regulate exocytosis and vesicle biogenesis.\",\n      \"method\": \"Amperometry, whole-cell patch clamping, electron microscopy in dysbindin-null sdy mice\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple direct physiological assays (amperometry, patch clamp, EM) in genetic null model\",\n      \"pmids\": [\"18504299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In sdy mice (dysbindin-null), steady-state levels of snapin were reduced. A 30-residue peptide in dysbindin (residues 90-119) mediates the interaction with snapin, and loss of dysbindin destabilizes snapin, suggesting dysbindin stabilizes snapin to regulate neurotransmission.\",\n      \"method\": \"Western blot in sdy mice, peptide binding assay defining interaction domain\",\n      \"journal\": \"Schizophrenia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — domain mapping + protein level change in null mouse, single lab\",\n      \"pmids\": [\"18774265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TRIM32 is an E3 ubiquitin ligase that binds and ubiquitinates dysbindin, targeting it for proteasomal degradation. TRIM32 binds dysbindin via yeast two-hybrid and augments its degradation; siRNA knockdown of TRIM32 in myoblasts elevated dysbindin levels. LGMD2H/STM-associated TRIM32 mutations (D487N and R394H) impair ubiquitin ligase activity toward dysbindin and are mislocalized; D487N binds dysbindin and its E2 enzyme but is defective in monoubiquitination.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, ubiquitination assay, siRNA knockdown, mutagenesis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro ubiquitination assay + mutagenesis + siRNA with protein level readout + multiple orthogonal methods\",\n      \"pmids\": [\"19349376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin regulates the surface expression of D2 dopamine receptors in cortical neurons. Loss of dysbindin (dys-/-) causes a robust increase in D2 (but not D1) receptor surface expression due to enhanced receptor recycling and insertion rather than reduced endocytosis. Dysbindin-null mice show decreased excitability of fast-spiking GABAergic interneurons in prefrontal cortex and striatum, and decreased inhibitory input to pyramidal neurons.\",\n      \"method\": \"Cell imaging, biochemical surface biotinylation, electrophysiology in dysbindin-knockout mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — imaging + biochemistry + electrophysiology in genetic knockout, multiple orthogonal methods\",\n      \"pmids\": [\"19887632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin controls hippocampal LTP by selectively regulating the surface expression of NMDA receptor subunit NR2A (but not NR2B). In dysbindin-null (Dys-/-) hippocampal neurons, surface NR2A expression is markedly increased, NR2A-mediated synaptic currents are enhanced, and LTP is augmented, while basal synaptic transmission, presynaptic properties, and LTD are normal. Exogenous dysbindin expression reduces NR2A surface expression.\",\n      \"method\": \"Imaging, biotinylation, electrophysiology (LTP, LTD, synaptic currents) in dysbindin-null mice, exogenous dysbindin expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (imaging, biochemistry, electrophysiology) in genetic null + rescue experiment\",\n      \"pmids\": [\"19955431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin is required presynaptically for retrograde homeostatic modulation of neurotransmission in Drosophila, functioning in a dose-dependent manner downstream or independently of calcium influx. Identified via electrophysiology-based forward genetic screen of >250 neuronally expressed genes.\",\n      \"method\": \"Forward genetic screen, electrophysiology at Drosophila NMJ, genetic epistasis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — unbiased forward genetic screen + electrophysiology + epistasis; highly cited\",\n      \"pmids\": [\"19965435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Brain BLOC-1 (the dysbindin-containing complex) biochemically interacts with a subset of SNARE proteins including SNAP-25 and syntaxin 13. Primary hippocampal neurons deficient in BLOC-1 display neurite outgrowth defects, indicating a role for the dysbindin-BLOC-1 complex in neurodevelopment.\",\n      \"method\": \"Co-immunoprecipitation, primary neuron culture with BLOC-1 deficiency, neurite outgrowth assay\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP with SNARE proteins + loss-of-function neurite phenotype, single lab\",\n      \"pmids\": [\"19546860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin directly interacts with the mu subunit of the AP-3 adaptor protein complex, as determined by co-immunoprecipitation and direct binding assay. Dysbindin partially co-localizes with AP-3 complex in mouse hippocampus and at presynaptic terminals. Suppression of dysbindin reduces presynaptic protein expression and glutamate release.\",\n      \"method\": \"Co-immunoprecipitation, direct binding assay, siRNA knockdown, glutamate release assay\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct binding assay + co-IP + functional knockdown; single lab\",\n      \"pmids\": [\"19428785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin interacts with Munc18-1 (a synaptic vesicle exocytosis regulator). Munc18-1 was co-immunoprecipitated with dysbindin from rat brain lysate and shown to directly interact with dysbindin in vitro. Part of dysbindin co-localizes with Munc18-1 at presynaptic terminals in hippocampal neurons.\",\n      \"method\": \"Affinity chromatography, mass spectrometry, co-immunoprecipitation, in vitro binding assay, co-localization\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro direct interaction + reciprocal co-IP from brain + co-localization\",\n      \"pmids\": [\"19573021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin promotes the post-endocytic sorting of specific GPCRs (D2 dopamine receptor, delta opioid receptor) to lysosomes. Dysbindin knockdown specifically reduced the trafficking of internalized D2 receptors to lysosomes (not endocytosis per se), increasing surface D2 expression. Dysbindin co-immunoprecipitated with GASP-1 and HRS (ESCRT component).\",\n      \"method\": \"RNA interference in HEK293 and HeLa cells, receptor trafficking assays (immunochemical, biochemical), co-immunoprecipitation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA + mechanistic trafficking dissection + co-IP with pathway components, single lab\",\n      \"pmids\": [\"20174469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dysbindin engages in c-Jun N-terminal kinase (JNK) activity regulation and actin cytoskeletal organization. siRNA-mediated knockdown of dysbindin in SH-SY5Y cells caused aberrant actin cytoskeleton organization; similar morphological abnormalities were observed in growth cones of sdy mouse hippocampal neurons. Dysbindin expression level correlates with JNK phosphorylation level.\",\n      \"method\": \"siRNA knockdown, immunofluorescence for actin, Western blot for p-JNK in cell lines and primary neurons from sdy mice\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss of function in cells and mouse model with cytoskeletal readout + signaling correlation; single lab\",\n      \"pmids\": [\"19094965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin-1 regulates D2-receptor trafficking, and dysbindin-null (dys-/-) mice show altered CaMKII and CaMKKβ expression in medial prefrontal cortex. Dys-/- pyramidal neurons in mPFC are hyperexcitable at baseline but hypoexcitable following D2 stimulation. These effects are reproduced by chronic D2 agonist treatment.\",\n      \"method\": \"Electrophysiology, Western blot, pharmacological treatment in dysbindin-null mice\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic null model + electrophysiology + molecular readouts; follows up prior mechanistic work\",\n      \"pmids\": [\"20956979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin-1 forms a ternary complex with WAVE2 and Abi-1. Dysbindin-1 binds WAVE2 (but not N-WASP) as identified by co-immunoprecipitation. Dysbindin-1 promotes the binding of WAVE2 to Abi-1. siRNA knockdown of dysbindin-1 in hippocampal neurons leads to generation of abnormally elongated immature dendritic protrusions, indicating a role in dendritic spine morphogenesis.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, immunofluorescence, dendritic spine morphology analysis\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP identifying complex + loss-of-function spine phenotype in primary neurons; single lab\",\n      \"pmids\": [\"20531346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Dysbindin-1 is a nucleocytoplasmic shuttling protein with a functional nuclear export signal (NES) mediating CRM1-dependent nuclear export (blocked by leptomycin B). Nuclear shuttling of dysbindin-1 regulates synapsin I expression; in sdy (dysbindin-null) mice, synapsin I protein and mRNA levels are reduced.\",\n      \"method\": \"Nuclear export inhibition (leptomycin B), NES mutagenesis, Western blot, qPCR in sdy mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological + mutagenesis approach + in vivo validation in null mice; single lab\",\n      \"pmids\": [\"20921223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dysbindin interacts directly with DISC1 (disrupted-in-schizophrenia 1). DISC1 aggresomes recruit dysbindin in neuroblastoma cells; domains involved map to DISC1 (residues 316-597) and dysbindin (residues 82-173). A direct interaction between soluble DISC1 and dysbindin was demonstrated in a cell-free system using E. coli-expressed proteins. Co-aggregation of DISC1 and dysbindin was found in postmortem brains of a subgroup of patients with chronic mental disease.\",\n      \"method\": \"Recombinant protein interaction (cell-free), co-expression in neuroblastoma cells, domain mapping, postmortem brain biochemistry\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro direct interaction + domain mapping + cell-based + human tissue validation; single lab\",\n      \"pmids\": [\"21531389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dysbindin and its BLOC-1 complex sort cargo from neuronal cell bodies to the synapse. PI4KIIα copurified with BLOC-1 and AP-3 in neuronal cells; PI4KIIα content is decreased in the dentate gyrus of dysbindin-null and AP-3-null mice due to failure to traffic from the cell body. In primary cortical neurons lacking AP-3 or BLOC-1, PI4KIIα fails to reach neurites.\",\n      \"method\": \"Co-purification, Western blot in null mice, primary neuron trafficking assay, PC12 cell sorting assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-purification + genetic null models + primary neuron functional trafficking assay; multiple orthogonal approaches\",\n      \"pmids\": [\"21998198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dysbindin-1 promotes neurite outgrowth by binding necdin and recruiting it to the cytoplasm, thereby relieving necdin's repression of p53 transcriptional activity. p53 target genes coronin 1b and rab13 are required for neurite outgrowth; knockdown of dysbindin-1 reduces their expression similar to p53 knockdown. Overexpression of p53 rescues the neurite outgrowth defect caused by dysbindin-1 knockdown. In sdy mouse brains, p21, coronin 1b, and Rab13 levels are reduced.\",\n      \"method\": \"Yeast two-hybrid (necdin identification), co-immunoprecipitation, siRNA knockdown, overexpression rescue, primary cortical neuron culture from sdy mice\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placed by epistasis (p53 rescue) + binding partner identification + in vivo validation in null mice; single lab\",\n      \"pmids\": [\"21502952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SILAC quantitative proteomics identified 24 proteins that associate with the BLOC-1 complex (containing dysbindin), including the COG complex (a Golgi apparatus tether) and antioxidant enzymes peroxiredoxins 1-2. Many of these interactors were altered in content/distribution in BLOC-1-deficient cells or tissues.\",\n      \"method\": \"SILAC quantitative proteomics, genetic analyses in dysbindin-null mice\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics + genetic null validation; identifies novel BLOC-1 interactions\",\n      \"pmids\": [\"22423091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Drosophila dysbindin (Ddysb) regulates glutamatergic and dopaminergic functions through two independent mechanisms: reduced Ddysb in presynaptic neurons suppresses glutamatergic synaptic transmission (causing memory impairment), while reduced Ddysb in glial cells causes hyperdopaminergic activity by altering expression of dopamine metabolic enzyme Ebony (leading to abnormal locomotion and mating orientation).\",\n      \"method\": \"Cell-type-specific RNAi in Drosophila, electrophysiology, behavioral analysis, Ebony expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — cell-type-specific dissection via genetic tools, two independent mechanisms established with behavior and physiology\",\n      \"pmids\": [\"22049342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dysbindin-1 null mice show reduced NMDAR-dependent synaptic potentiation in CA1, which is rescued by bath application of the NMDAR co-agonist glycine (10 μM). Dysbindin-null mice also exhibit deficits in contextual fear conditioning, indicating impaired hippocampal memory processes linked to NMDAR hypofunction.\",\n      \"method\": \"Field electrophysiology in acute hippocampal slices, pharmacological rescue with glycine, fear conditioning behavioral test\",\n      \"journal\": \"Hippocampus\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology + pharmacological rescue + behavioral test in genetic null; single lab\",\n      \"pmids\": [\"24446171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dysbindin-null mutant mice show decreased ready-releasable pool of synaptic vesicles, decreased quantal size, decreased release probability, and deficits in endo- and exocytosis rate in prefrontal cortical neurons. Additionally, dysbindin-null mice show decreased intracellular calcium, reduced expression of L- and N-type Ca2+ channels, and reduced levels of synaptic vesicle trafficking and priming proteins.\",\n      \"method\": \"Electrophysiology, vesicle imaging, calcium imaging, Western blot in dysbindin-null mice\",\n      \"journal\": \"Schizophrenia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple physiological assays in genetic null model; single lab\",\n      \"pmids\": [\"23473812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dysbindin is required to stabilize dendritic protrusions. In dysbindin-null neurons, dendritic protrusions are hyperactive in formation, retraction, and conversion between types. This hyperactivity is attributed in part to decreased CaMKIIα activity resulting from increased inhibition of CaMKIIα by Abi1 (which accumulates when dysbindin is absent).\",\n      \"method\": \"Time-lapse imaging in hippocampal neurons, genetic null model, CaMKIIα activity assay\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live imaging + genetic null + molecular pathway placement (Abi1-CaMKIIα); single lab\",\n      \"pmids\": [\"25297099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dysbindin-1C isoform (but not dysbindin-1A) is specifically localized in hilar glutamatergic mossy cells of the dentate gyrus. Dysbindin-1C deficiency leads to a decrease in mossy cells, which causes delayed maturation of newborn neurons in the dentate gyrus, indicating an isoform-specific, non-cell-autonomous role in adult hippocampal neurogenesis.\",\n      \"method\": \"Isoform-specific localization, comparison of sdy (1A+1C null) vs. muted (1A destabilized, 1C intact) mice, adult neurogenesis assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — isoform-specific localization + comparative genetic models + neurogenesis assay; single lab\",\n      \"pmids\": [\"25157109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dysbindin/BLOC-1 and ATP7A (copper transporter mutated in Menkes disease) genetically and biochemically interact. Loss of dysbindin/BLOC-1 alters the transcriptional profile of copper-regulatory and dependent factors in the hippocampus of null mice and alters susceptibility to toxic copper challenges in mammalian cells and Drosophila, without affecting baseline tissue copper content.\",\n      \"method\": \"Co-immunoprecipitation, genetic epistasis in Drosophila and mice, transcriptional profiling, copper toxicity assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical interaction + cross-species genetic epistasis + functional copper susceptibility assay\",\n      \"pmids\": [\"26199316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dysbindin-1 loss reduces BDNF exocytosis from cortical excitatory neurons. This reduction in BDNF exocytosis transsynaptically reduces the number of inhibitory synapses formed on excitatory neurons. Exogenous BDNF application rescues the inhibitory synaptic deficits caused by reduced dysbindin-1 in cultured and slice cultures.\",\n      \"method\": \"TIRF microscopy for BDNF exocytosis, whole-cell recordings, immunohistochemistry, pharmacological rescue in dysbindin mutant mice\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — TIRF live imaging + electrophysiology + pharmacological rescue; multiple orthogonal methods\",\n      \"pmids\": [\"26386481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"N-ethylmaleimide-sensitive factor (NSF) is a binding partner of dysbindin/BLOC-1; NSF content is downregulated in dysbindin/BLOC-1-deficient neuroectodermal cells and iPSC-derived human neurons. Human dysbindin/BLOC-1 co-precipitates with NSF. In Drosophila, the dysbindin mutant phenotype of impaired homeostatic synaptic plasticity is fully rescued by presynaptic expression of either dysbindin or NSF.\",\n      \"method\": \"Quantitative proteomics, co-immunoprecipitation, Drosophila genetic rescue experiment, electrophysiology\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — proteomics + co-IP + in vivo genetic rescue of synaptic plasticity phenotype; multiple methods\",\n      \"pmids\": [\"25972187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss of dysbindin-1 impairs hippocampal group 1 metabotropic glutamate receptor (mGluRI) function: mGluRI agonist (DHPG)-induced ERK1/2 phosphorylation is markedly reduced in sdy mouse hippocampal synaptosomes. DHPG-induced LTD at CA1 synapses is also significantly reduced. A positive allosteric modulator of mGluR5 (CDPPB) rescues short-term object recognition and spatial learning deficits in sdy mice.\",\n      \"method\": \"Synaptoneurosomes from sdy mice, Western blot for ERK1/2 phosphorylation, field electrophysiology for LTD, pharmacological rescue with CDPPB\",\n      \"journal\": \"Frontiers in behavioral neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical signaling + electrophysiology + pharmacological rescue in null mouse; single lab\",\n      \"pmids\": [\"25859193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Drosophila BLOC-1 (containing dysbindin) is present in neurons and regulates synaptic output, morphology, and homeostatic plasticity. Homozygous loss-of-function alleles of dysb or Blos1, or compound heterozygotes, impair neurotransmitter release, synapse morphology, and homeostatic plasticity at the larval NMJ and impair olfactory habituation. Phenotypes are differentially sensitive to genetic dosage of BLOC-1 alleles.\",\n      \"method\": \"Drosophila genetics, electrophysiology at NMJ, behavioral assay, biochemical confirmation of BLOC-1 in neurons\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic dosage analysis + electrophysiology + behavior in Drosophila model; single lab\",\n      \"pmids\": [\"25568125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The Arp2/3 actin polymerization complex is identified downstream of dysbindin/BLOC-1 by quantitative proteomics; Arp2/3 subunits are downregulated by BLOC-1 loss of function. Arp2/3, dysbindin, and BLOC-1 subunits biochemically and genetically interact, modulating Drosophila synapse morphology and homeostatic plasticity. Loss of BLOC-1 affects actin dynamics in early endosomes.\",\n      \"method\": \"Quantitative mass spectrometry, co-immunoprecipitation, genetic interaction in Drosophila, actin dynamics assay\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — quantitative proteomics + co-IP + cross-species genetic validation + functional actin assay; multiple methods\",\n      \"pmids\": [\"27927957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TRIM24 is identified as a novel dysbindin binding partner in cardiac muscle (yeast two-hybrid + co-immunoprecipitation). TRIM24 protects dysbindin from TRIM32-mediated ubiquitin-dependent degradation, promoting SRF-dependent hypertrophic signaling. TRIM32 degrades dysbindin in cardiomyocytes and also promotes apoptosis via p53 and caspase-3/-7 activation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, co-immunostaining, overexpression/knockdown in neonatal cardiomyocytes, SRF reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — yeast two-hybrid + co-IP + functional overexpression assay; single lab\",\n      \"pmids\": [\"28465353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Genetic variations reducing dysbindin-1 expression interact with antipsychotic drugs to improve executive functions in schizophrenia. The molecular mechanism involves an imbalance between short and long isoforms of dopamine D2 receptors, leading to enhanced presynaptic D2 function in the prefrontal cortex, as demonstrated in postmortem human brains and dysbindin-deficient mice treated with antipsychotics.\",\n      \"method\": \"Postmortem human brain analysis (D2R isoforms), genetically modified mice, pharmacological treatment, ex vivo and in vivo analyses\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human postmortem + mouse genetic model + pharmacological intervention; single lab\",\n      \"pmids\": [\"29891954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dysbindin-1B aggregates into cell-invasive deposits and propagates between neurons via exosome-mediated transmission. Dysbindin-1B aggregates are neurotoxic and exert toxic effects on recipient neurons distant from the initial aggregation site through exosomal spread in mouse brain.\",\n      \"method\": \"Overexpression in mice, exosome isolation, neuronal toxicity assay, live imaging\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, isoform-specific aggregation with exosome mechanism; limited mechanistic follow-up\",\n      \"pmids\": [\"25704251\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Dysbindin (DTNBP1) is a coiled-coil protein that assembles as a core subunit of the octameric BLOC-1 complex, which mediates vesicle trafficking from endosomes to lysosome-related organelles and from neuronal cell bodies to synapses via interaction with AP-3; at the presynapse, dysbindin regulates synaptic vesicle biogenesis, the size of the readily releasable pool, and exocytosis (including glutamate and BDNF release), and is required for homeostatic synaptic plasticity; postsynaptically, it controls NR2A surface expression to modulate LTP, and regulates D2 dopamine receptor trafficking to lysosomes, thereby influencing GABAergic interneuron excitability and prefrontal cortical function; dysbindin protein levels are regulated by TRIM32 (E3 ubiquitin ligase) and TRIM24 (protective against TRIM32-mediated degradation), and the protein shuttles between cytoplasm and nucleus where it controls synapsin I expression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DTNBP1 (dysbindin) is a coiled-coil protein that functions as a core subunit of the BLOC-1 complex to regulate vesicle trafficking from endosomes to lysosome-related organelles and from neuronal cell bodies to synapses, with loss-of-function mutations causing Hermansky-Pudlak syndrome type 7 [PMID:12923531]. At the presynapse, dysbindin controls synaptic vesicle biogenesis, the size of the readily releasable pool, quantal release, and exocytosis of glutamate and BDNF, and is required for homeostatic synaptic plasticity through a mechanism involving NSF and acting downstream or independently of calcium influx [PMID:18504299, PMID:19965435, PMID:25972187, PMID:26386481]. Postsynaptically, dysbindin regulates surface expression of NR2A-containing NMDA receptors to modulate LTP and directs D2 dopamine receptor sorting to lysosomes, thereby controlling GABAergic interneuron excitability in prefrontal cortex [PMID:19955431, PMID:19887632]. Dysbindin protein levels are regulated by TRIM32-mediated ubiquitin-dependent degradation counteracted by TRIM24, and dysbindin undergoes CRM1-dependent nucleocytoplasmic shuttling to control synapsin I transcription [PMID:19349376, PMID:28465353, PMID:20921223].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"The initial identification of dysbindin as a dystrobrevin-binding coiled-coil protein established it as a component of the dystrophin-associated protein complex in muscle and brain, localizing it to synaptic terminals.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-immunoprecipitation, and immunofluorescence in muscle and brain tissue\",\n      \"pmids\": [\"11316798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the dystrobrevin interaction was unknown\", \"Whether dysbindin operated independently of the DPC was unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery that dysbindin is an obligate subunit of BLOC-1 and that its loss causes Hermansky-Pudlak syndrome type 7 reframed dysbindin from a DPC component to a vesicle trafficking regulator, and later work showed BLOC-1-assembled dysbindin does not physiologically bind dystrobrevins.\",\n      \"evidence\": \"Sandy (sdy) mouse model, human HPS-7 mutation analysis, BLOC-1 complex identification; subsequently challenged by recombinant protein and endogenous co-IP experiments\",\n      \"pmids\": [\"12923531\", \"16448387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific vesicle trafficking step controlled by dysbindin-BLOC-1 was not defined\", \"Brain-specific vs. ubiquitous function of BLOC-1 was unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Gain- and loss-of-function studies in cortical neurons established that dysbindin positively regulates presynaptic protein expression (SNAP25, synapsin I) and glutamate release, linking it to excitatory neurotransmission and PI3K-Akt survival signaling.\",\n      \"evidence\": \"Overexpression and siRNA knockdown in primary cortical neurons with glutamate release assays and Akt phosphorylation readouts\",\n      \"pmids\": [\"15345706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direction of SNAP25 regulation was contradicted by PC12 cell data (PMID:16701550)\", \"Whether glutamate release effects were cell-autonomous was untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of snapin as a direct synaptic vesicle-associated partner of dysbindin, with immunoelectron microscopy placing dysbindin at synaptic vesicles and postsynaptic densities, provided ultrastructural evidence for its dual pre- and postsynaptic roles.\",\n      \"evidence\": \"In vitro binding, reciprocal co-IP, subcellular fractionation, and immunoelectron microscopy in mouse hippocampus\",\n      \"pmids\": [\"16980328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of the dysbindin-snapin interaction on vesicle release was not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Electrophysiological and ultrastructural analysis of dysbindin-null mice revealed that dysbindin is required for normal vesicle biogenesis, quantal size, release probability, and readily releasable pool size, establishing its direct role in regulated exocytosis.\",\n      \"evidence\": \"Amperometry, whole-cell patch clamp, and electron microscopy in sdy mouse neuroendocrine cells and hippocampal synapses\",\n      \"pmids\": [\"18504299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular intermediates between BLOC-1 and vesicle biogenesis machinery were unknown\", \"Whether defects were BLOC-1-dependent was not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A convergent set of 2009 studies defined dysbindin's postsynaptic functions: it controls surface expression of D2 dopamine receptors (via post-endocytic lysosomal sorting) and NR2A-containing NMDA receptors, thereby modulating GABAergic interneuron excitability and hippocampal LTP, respectively. Concurrently, a Drosophila forward genetic screen established dysbindin as essential for presynaptic homeostatic synaptic plasticity.\",\n      \"evidence\": \"Surface biotinylation, receptor trafficking, and electrophysiology in dys−/− mice (D2R and NR2A); unbiased electrophysiology-based screen plus epistasis at Drosophila NMJ\",\n      \"pmids\": [\"19887632\", \"19955431\", \"19965435\", \"20174469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which dysbindin directs receptor-specific sorting remained unclear\", \"Identity of the calcium-independent step in homeostatic plasticity was not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"TRIM32 was identified as the E3 ubiquitin ligase that ubiquitinates and targets dysbindin for proteasomal degradation, with LGMD2H-associated TRIM32 mutations impairing this activity, connecting dysbindin turnover to muscle disease.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro ubiquitination assay, siRNA knockdown in myoblasts, mutagenesis of disease-associated TRIM32 alleles\",\n      \"pmids\": [\"19349376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRIM32-mediated regulation of dysbindin occurs in neurons was untested\", \"Physiological consequence of elevated dysbindin in TRIM32 mutant muscle was not shown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Direct interactions of BLOC-1/dysbindin with AP-3 adaptor, SNARE proteins (SNAP-25, syntaxin 13), and Munc18-1 placed the complex within the molecular machinery of vesicle sorting and fusion, and revealed neurite outgrowth as a BLOC-1-dependent developmental process.\",\n      \"evidence\": \"Co-immunoprecipitation, direct binding assays, affinity chromatography/mass spectrometry, neurite outgrowth assays in BLOC-1-deficient neurons\",\n      \"pmids\": [\"19546860\", \"19428785\", \"19573021\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Hierarchy among AP-3, SNARE, and Munc18-1 interactions was not established\", \"Whether neurite outgrowth defects are BLOC-1-specific or a general SNARE trafficking phenotype was unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Dysbindin was found to undergo CRM1-dependent nucleocytoplasmic shuttling and to regulate synapsin I transcription from the nucleus, revealing a non-canonical nuclear function beyond vesicle trafficking.\",\n      \"evidence\": \"Leptomycin B treatment, NES mutagenesis, qPCR and Western blot for synapsin I in sdy mice\",\n      \"pmids\": [\"20921223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The transcription factor(s) or chromatin targets mediating synapsin I regulation were not identified\", \"Fraction of dysbindin in nucleus vs. cytoplasm under physiological conditions was not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"BLOC-1/AP-3-dependent sorting was shown to deliver specific cargo (PI4KIIα) from neuronal cell bodies to synapses, providing a concrete example of how dysbindin-containing BLOC-1 controls synaptic protein composition.\",\n      \"evidence\": \"Co-purification of PI4KIIα with BLOC-1/AP-3, reduced PI4KIIα in dentate gyrus of dysbindin-null and AP-3-null mice, neurite trafficking assay\",\n      \"pmids\": [\"21998198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full repertoire of BLOC-1/AP-3-dependent synaptic cargoes was not defined\", \"Whether PI4KIIα loss accounts for synaptic vesicle biogenesis defects was unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"NSF was identified as a key effector downstream of dysbindin/BLOC-1: NSF is downregulated by BLOC-1 deficiency, and presynaptic NSF expression fully rescues the homeostatic plasticity defect in Drosophila dysbindin mutants, establishing a mechanistic link between BLOC-1 and SNARE-dependent membrane fusion.\",\n      \"evidence\": \"Quantitative proteomics, co-immunoprecipitation, genetic rescue experiment with electrophysiology at Drosophila NMJ\",\n      \"pmids\": [\"25972187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NSF rescue reflects restored vesicle fusion per se or secondary effects on vesicle pools was not distinguished\", \"Mammalian validation of the NSF rescue was lacking\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"TIRF microscopy demonstrated that dysbindin loss specifically reduces BDNF exocytosis from excitatory neurons, which transsynaptically decreases inhibitory synapse formation — a circuit-level mechanism linking dysbindin to excitatory-inhibitory balance.\",\n      \"evidence\": \"TIRF live imaging of BDNF vesicle fusion, electrophysiology, immunohistochemistry, and BDNF rescue in dysbindin mutant cortical neurons and slices\",\n      \"pmids\": [\"26386481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BDNF exocytosis defect is BLOC-1-dependent or involves a BLOC-1-independent dysbindin function was not resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The Arp2/3 actin polymerization complex was placed downstream of BLOC-1 as a regulator of endosomal actin dynamics, synapse morphology, and homeostatic plasticity, integrating dysbindin's vesicle trafficking function with actin cytoskeletal remodeling.\",\n      \"evidence\": \"Quantitative mass spectrometry, co-immunoprecipitation, Drosophila genetic interaction, endosomal actin dynamics assay\",\n      \"pmids\": [\"27927957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect regulation of Arp2/3 by BLOC-1 was not resolved\", \"How Arp2/3-dependent actin remodeling connects to vesicle biogenesis defects was untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"TRIM24 was identified as a protective factor that counteracts TRIM32-mediated degradation of dysbindin in cardiomyocytes, linking dysbindin stability to SRF-dependent hypertrophic signaling in the heart.\",\n      \"evidence\": \"Yeast two-hybrid, co-immunoprecipitation, overexpression/knockdown in neonatal cardiomyocytes, SRF reporter assay\",\n      \"pmids\": [\"28465353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TRIM24-TRIM32 competition for dysbindin occurs in neurons was not tested\", \"Structural basis for competitive binding was not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the full cargo repertoire of BLOC-1/AP-3-dependent sorting in neurons; the transcriptional mechanism by which nuclear dysbindin regulates synapsin I; whether BLOC-1-dependent and BLOC-1-independent functions of dysbindin can be cleanly separated in vivo; and the structural basis for dysbindin's assembly into BLOC-1 and its interaction with diverse partners.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of dysbindin or BLOC-1 with dysbindin\", \"Nuclear transcriptional targets beyond synapsin I are undefined\", \"Separation of BLOC-1-dependent vs. independent functions in mammalian neurons not achieved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 14, 22]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [19, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 20]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4, 7, 22]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [16, 35]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 7, 14, 22]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 36]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [10, 11, 12, 31]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [10, 11, 33]}\n    ],\n    \"complexes\": [\n      \"BLOC-1\"\n    ],\n    \"partners\": [\n      \"PLDN\",\n      \"SNAPIN\",\n      \"MUTED\",\n      \"AP3B1\",\n      \"TRIM32\",\n      \"TRIM24\",\n      \"NSF\",\n      \"MUNC18-1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}